Outlook Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Outlook Therapeutics, Inc. (OTLK) on May 1, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The report addresses a specific corporate event under Item 8.01 (Other Events).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a change in corporate address and does not contain financial statements or performance data.
Material Changes
Effective May 1, 2024, the Company moved its principal executive offices (headquarters) to a new location:
- New Address: 111 S. Wood Avenue, Unit #100, Iselin, NJ 08830
- Former Address: 485 Route 1 South, Building F, Suite 320, Iselin, New Jersey
- Contact Information: The telephone number remains unchanged at (609) 619-3990.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly an administrative notice regarding the relocation of the company's headquarters.
Key Facts for Investor Verification
- Verify the new mailing address for official correspondence: 111 S. Wood Avenue, Unit #100, Iselin, NJ 08830.
- Confirm that the company's primary phone number remains (609) 619-3990.
- Note that this filing contains no financial updates or changes to the company's strategic outlook.